Diabetic dermopathy

LAST UPDATED: Nov 21, 2021

Introduction

Diabetic dermopathy is a term used to describe the small, round, brown atrophic skin lesions that occur on the shins of patients with diabetes. Diabetic dermopathy is the commonest skin condition that occurs in patients with diabetes mellitus and is associated with other microvascular complications of diabetes such as retinopathy, nephropathy and neuropathy and also with large vessel disease.

This chapter is set out as follows:


Aetiology

  • The underlying mechanism for diabetic dermopathy is unknown

History

  • Diabetic dermopathy is more common in older patients and those with longstanding diabetes
  • In older patients diabetic dermopathy was found to occur after a shorter duration of diabetes, whereas in younger patients lesions occurred only after ten years in patients less than 20 years of age
  • Lesions are asymptomatic 

Clinical findings

Distribution

  • ​Usually the shins in a bilateral symmetrical distribution
  • Rarely the arms, thighs, trunk and abdomen

Morphology

  • Lesions begin spontaneously as non-blanching, scaly, red or purple, round or oval macules or papules. There may be induration, with a central depression or vesiculation
  • Established lesions are generally round, brown, and atrophic less than 1cm diameter, some may be elongated and up to 2.5cm in diameter
  • Some lesions may have fine scale 

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Investigations

  • Histological changes include epidermal atrophy with flattening of the rete ridges, dermal fibroblastic proliferation, altered collagen, dermal oedema and an increase in dermal capillaries, with a perivascular inflammatory infiltrate, changes to the vessel walls and melanin and haemosiderin deposition (reference: Rook's Textbook of Dermatology)

Management

  • Lesions lasts on average 18-24 months, before fading to minimally atrophic macules, or clearing completely
  • No treatment is recommended or has been shown to be effective. Cosmetic camouflage may be used to disguise the appearance of the skin lesions if required

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco